Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology and Therapeutics
|
October 23, 1997
Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
C Olbricht, C Wanner, T Eisenhauer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 16, 2017
Physiologically Based Pharmacokinetic Model Predictions of Panobinostat (LBH589) as a Victim and Perpetrator of Drug-Drug Interactions
Heidi J Einolf, Wen Lin, Christina S Won, et al.
Wiener Klinische Wochenschrift
|
April 14, 2000
[SIDS prevention program in Tyrol]
W Sperl, U Kiechl-Kohlendorfer, U Pupp, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 31, 2012
Disposition and metabolism of [¹⁴C]PTZ601 in healthy volunteers
J Flarakos, L S L Ting, Y Du, et al.
Biochemical Pharmacology
|
September 15, 1988
Dissociation of covalent binding from the oxidative effects of acetaminophen. Studies using dimethylated acetaminophen derivatives
R B Birge, J B Bartolone, E V Nishanian, et al.
Transplantation Proceedings
|
December 1, 1996
Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine
V Kliem, C Wanner, T Eisenhauer, et al.
British Journal of Clinical Pharmacology
|
December 22, 1999
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency
R Greenbaum, P Zucchelli, A Caspi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 17, 2008
Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans
Handan He, Phi Tran, Hequn Yin, et al.
Arzneimittel-Forschung
|
September 1, 1990
[Future requirements for the composition and working methods of ethics commissions for the viewpoint of the Association of Physicians in the Pharmaceutical Industry e. V.(FAPI)]
J A Schwarz, V Gladigau, H D Görlich, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 4, 2016
Utilization of Stable Isotope Labeling to Facilitate the Identification of Polar Metabolites of KAF156, an Antimalarial Agent
Su-Er W Huskey, Ry R Forseth, Hongmei Li, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology and Therapeutics
|
October 23, 1997
Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
C Olbricht, C Wanner, T Eisenhauer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 16, 2017
Physiologically Based Pharmacokinetic Model Predictions of Panobinostat (LBH589) as a Victim and Perpetrator of Drug-Drug Interactions
Heidi J Einolf, Wen Lin, Christina S Won, et al.
Wiener Klinische Wochenschrift
|
April 14, 2000
[SIDS prevention program in Tyrol]
W Sperl, U Kiechl-Kohlendorfer, U Pupp, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 31, 2012
Disposition and metabolism of [¹⁴C]PTZ601 in healthy volunteers
J Flarakos, L S L Ting, Y Du, et al.
Biochemical Pharmacology
|
September 15, 1988
Dissociation of covalent binding from the oxidative effects of acetaminophen. Studies using dimethylated acetaminophen derivatives
R B Birge, J B Bartolone, E V Nishanian, et al.
Transplantation Proceedings
|
December 1, 1996
Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine
V Kliem, C Wanner, T Eisenhauer, et al.
British Journal of Clinical Pharmacology
|
December 22, 1999
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency
R Greenbaum, P Zucchelli, A Caspi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 17, 2008
Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans
Handan He, Phi Tran, Hequn Yin, et al.
Arzneimittel-Forschung
|
September 1, 1990
[Future requirements for the composition and working methods of ethics commissions for the viewpoint of the Association of Physicians in the Pharmaceutical Industry e. V.(FAPI)]
J A Schwarz, V Gladigau, H D Görlich, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 4, 2016
Utilization of Stable Isotope Labeling to Facilitate the Identification of Polar Metabolites of KAF156, an Antimalarial Agent
Su-Er W Huskey, Ry R Forseth, Hongmei Li, et al.
Page
of 8